Drug Class
tyrosine kinase inhibitor
Type
ingredient
Active Ingredient
ponatinib
📋Overview
Ponatinib is a type of targeted cancer medication known as a tyrosine kinase inhibitor. It is primarily associated with certain types of leukemia, such as chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). Ponatinib works by blocking specific proteins that promote the growth of cancer cells. It is often considered in cases where other treatments have not been effective or when specific genetic mutations are present.
📚References
Information from MedlinePlus.gov (NIH).
Found an Error?
Help us keep this information accurate. If you notice any incorrect details, please submit a correction request.
Find Discounts for Ponatinib
Hospitals.net Disclosure
Hospitals.net is an independent healthcare information platform and does not provide, administer, or guarantee prescription discounts, pricing, coupons, or pharmacy participation. All discount pricing and availability shown above are provided by RxGo and its partners and are subject to change without notice.
Hospitals.net may receive a commission or referral fee if you choose to use this prescription discount service. This does not affect the price you pay at the pharmacy. Hospitals.net is not responsible for pricing accuracy, pharmacy participation, or the fulfillment of any discount offers.